Amyris Acquires MenoLabs
April 12, 2022
Amyris, a publicly traded synthetic biotechnology company, has acquired MenoLabs, a DTC women's wellness brand focused on perimenopause and menopause supplements and a symptom-tracking app. The deal is intended to accelerate Amyris' position in the menopause market by combining MenoLabs' subscription-based consumer business, app data, and product formulations with Amyris' fermentation technology and consumer brand capabilities.
- Buyers
- Amyris
- Targets
- MenoLabs
- Sellers
- Owners of MenoLabs (founders/management team)
- Industry
- Consumer Products
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Dr. Reddy's Acquires MenoLabs Women’s Supplement Brand from Amyris
January 5, 2024
Consumer Products
Dr. Reddy's Laboratories has acquired the MenoLabs dietary supplement portfolio and accompanying MenoLife health tracker app from Amyris as part of Amyris' Chapter 11 asset sale, winning the assets in an auction for $3.0 million. The acquisition adds seven branded menopause- and healthy-aging-focused supplements sold primarily via DTC e-commerce and marketplaces to Dr. Reddy's U.S. self-care and wellness portfolio to accelerate growth in women's nutritional and wellness markets.
-
Unified Women's Healthcare Acquires Gennev
October 18, 2022
Healthcare Services
Unified Women's Healthcare has acquired Gennev, a leading digital menopause care platform, to expand its menopause and women's health capabilities across the U.S. Financial terms were not disclosed; the acquisition will integrate Gennev's telehealth network of OB-GYNs, dietitians and health coaches with Unified's affiliated provider network.
-
Altos Labs Acquires Dorian Therapeutics
May 23, 2025
Biotechnology
Altos Labs has acquired Stanford spinout Dorian Therapeutics, a preclinical senotherapeutics startup developing small-molecule "senoblockers." Financial terms were not disclosed; Altos said the deal broadens its cellular rejuvenation capabilities by adding Dorian’s epigenetic senescence-targeting technology and preclinical programs in lung fibrosis and osteoarthritis.
-
Allergy Research Group Acquires Certain Assets of Metabolic Maintenance
January 15, 2025
Consumer Products
Allergy Research Group (ARG), a portfolio company backed by HPH III, has acquired certain assets of Metabolic Maintenance, a provider of physician-recommended nutritional supplements based in Sisters, Oregon. The add-on acquisition, announced by WM Partners, will integrate Metabolic Maintenance under the ARG platform to expand ARG's practitioner-channel product offering—particularly in mental well-being, stress management and mood support; terms were not disclosed.
-
Vi Labs Acquires Motus Consumer Insights
December 12, 2022
Marketing & Advertising
Vi Labs has acquired Motus Consumer Insights to combine Motus's member-acquisition analytics, site selection, and marketing BI capabilities with Vi's AI-powered member engagement and retention platform. The deal creates an end-to-end solution for digital health enterprises to identify high-value prospects, optimize site selection, and drive engagement and lifetime value.
-
FemTec Health Acquires Nutrimedy
July 25, 2022
Healthcare Services
FemTec Health has acquired Nutrimedy, an evidence-based clinical nutrition platform that offers AI-enabled photo food recognition and support for 50+ medical conditions. The acquisition adds real-time, personalized nutrition and dietitian access to FemTec's Awesome Woman subscription suite, expanding the company's women's-health capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.